FDA.reportPublic FDA data

Gold Bond Medicated Pain and Itch Relief

Manufacturer
Chattem, Inc.
Effective date
2026-01-14
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-06-01 01:32:36

Label at a glance#

ProductGold Bond Medicated Pain and Itch Relief
Active ingredientLIDOCAINE HYDROCHLORIDE
Label structure7 sections

Dosage and administration

adults and children 12 years of age and older :   apply a thin layer to affected area not more than 3 to 4 times daily children under 12 years of age : consult a doctor

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Gold Bond®   Medicated

Pain & Itch Relief Cream with Lidocaine

Drug Facts

Purpose

OTC - PURPOSE SECTION

Lidocaine HCl 4%.............................................................................................................................Topical anesthetic

Use

INDICATIONS & USAGE SECTION

for temporary relief of pain and itching associated with:

■ minor burns ■ sunburn ■ minor cuts ■ scrapes ■ insect bites ■ minor skin irritations

Warnings

WARNINGS SECTION

For external use only

Do not use

OTC - DO NOT USE SECTION

■ in large quantities, particularly over raw surfaces or blistered areas ■ on deep or puncture wounds

When using this product

OTC - WHEN USING SECTION

■ use only as directed. Read and follow all directions and warnings on this label.  

■ avoid contact with eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

■ condition worsens

■ symptoms persist for more than 7 days or clear up and occur again within a few days

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center immediately.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years of age and older: apply a thin layer to affected area not more than 3 to 4 times daily

children under 12 years of age: consult a doctor

Inactive ingredients:

INACTIVE INGREDIENT SECTION

acrylates/C10-30 alkyl acrylate crosspolymer, alcohol denat. (15%), aloe barbadensis leaf juice, aminomethyl propanol, C30-45 alkyl cetearyl dimethicone crosspolymer, caprylyl methicone, cetearyl alcohol, ceteth-20 phosphate, dicetyl phosphate, dimethicone, disodium EDTA, ethylhexylglycerin, glyceryl stearate, methylparaben, steareth-21, water

Close cap tightly between uses.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GOLD BOND
Maximum Strength
Pain and Itch Relief Cream
Net wt.1.75 oz (49 g)

PRINCIPAL DISPLAY PANEL GOLD BOND Maximum Strength Pain and Itch Relief Cream Net wt.1.75 oz (49 g)PRINCIPAL DISPLAY PANEL GOLD BOND Maximum Strength Pain and Itch Relief Cream Net wt.1.75 oz (49 g)

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1010895lidocaine HCl 4 % Topical CreamPSN3
1010895lidocaine hydrochloride 40 MG/ML Topical CreamSCD3
1010895lidocaine hydrochloride 4 % Topical CreamSY3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
LIDOCAINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
070fbed5-7088-434a-a7ce-f2a64d8d40acProduct name220260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80fProduct name520250819
860a93dc-4863-49cc-b284-6bbe8191bc48Product name420250214
eaba870a-6a9d-442e-8643-87b3f558a451Product name120250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86Product name120230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57Product name320210602
aed701d5-9c75-dfaf-7154-cde46179faeaProduct name920200313
fa8b5901-e681-426f-82fe-54f6d81ec698Product name420180619
332d03e4-aa24-4b11-841a-02bf41081920Product name120171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070Product name120171221
68ed98f8-24c2-44a0-944a-6d36e82ce25aProduct name120141222
1cd42bc2-a430-c72b-636d-991b235fbf80Product name120140508
49fa150c-f0de-cce7-3d9c-993ed81c5698Product name120140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ffProduct name120140508
9137811f-f279-8640-5aeb-99fa2145d64dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
41167-0529-0Gold Bond Medicated Pain and Itch Relief1 in 1 CARTONCREAM13
41167-0529-0Gold Bond Medicated Pain and Itch Relief49 g in 1 BOTTLE, PLASTICCREAM493

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
41167-052941167-0529-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Name, UNII, Kind table
NameUNIIKind
LIDOCAINE HYDROCHLORIDEV13007Z41AACTIR
ALCOHOL3K9958V90MIACT
ALOE VERA LEAFZY81Z83H0XIACT
AMINOMETHYLPROPANOLLU49E6626QIACT
C30-45 ALKYL CETEARYL DIMETHICONE CROSSPOLYMER4ZK9VP326RIACT
CAPRYLYL TRISILOXANEQ95M2P1KJLIACT
CETOSTEARYL ALCOHOL2DMT128M1SIACT
CETETH-20 PHOSPHATE921FTA1500IACT
DIHEXADECYL PHOSPHATE2V6E5WN99NIACT
DIMETHICONE92RU3N3Y1OIACT
EDETATE DISODIUM7FLD91C86KIACT
ETHYLHEXYLGLYCERIN147D247K3PIACT
GLYCERYL MONOSTEARATE230OU9XXE4IACT
METHYLPARABENA2I8C7HI9TIACT
STEARETH-2153J3F32P58IACT
WATER059QF0KO0RIACT
CARBOMER INTERPOLYMER TYPE A (55000 CPS)59TL3WG5COIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Gold Bond Medicated Pain and Itch ReliefLIDOCAINE HYDROCHLORIDEChattem, Inc.5767362c-83af-494e-a815-a13f2cb093ef2026-01-14WarningsExact identifier
ndc (package): 41167-0529-0
ndc (product): 41167-0529
ndc11 (package): 41167052900
spl id: a4548a1b-2745-42ed-ba2f-38c865f13cd4
spl set id: 5767362c-83af-494e-a815-a13f2cb093ef

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.